Inspiratory Muscle Training in Ehlers Danlos Patients

Evaluation of the effect of inspiratory muscle training in Ehlers Danlos patients

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium
        • Clinique Universitaire Saint-Luc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • a diagnosis for Ehlers Danlos syndrome combining genetics and clinical examination
  • no infectious exacerbation in the last four weeks

Exclusion Criteria:

  • respiratory comorbidities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Inspiratory muscle training group
Threshold inspiratory muscle training
Inspiratory muscle training
No Intervention: Control group
No training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
inspiratory muscle strength measured by sniff nasal inspiratory pressure
Time Frame: 2 minutes
2 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
walked distance measured by six minutes walking test
Time Frame: 6 minutes
6 minutes
lung function by spirometry
Time Frame: 5 minutes
5 minutes
anxiety by hospital anxiety depression scale
Time Frame: 2 minutes
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

January 4, 2016

First Submitted That Met QC Criteria

January 4, 2016

First Posted (Estimate)

January 5, 2016

Study Record Updates

Last Update Posted (Estimate)

April 20, 2016

Last Update Submitted That Met QC Criteria

April 19, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • EDS-IMT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ehlers Danlos

Clinical Trials on Threshold inspiratory muscle training

3
Subscribe